UBS Group
ISPC icon

UBS Group’s iSpecimen ISPC Stock Holding History

UBS Group’s Portfolio ISPC Stock Details ISPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.44K Buy
1,344
+1,183
+735% +$13.3K ﹤0.01% 8506
2025
Q4 		$1.68K Buy
+161
New +$4.08K ﹤0.01% 9498
2025
Q3 		– Sell
-351
Closed -$13.8K – 10598
2025
Q2 		$13.8K Sell
351
-192
-35% -$8.94K ﹤0.01% 8685
2025
Q1 		$23K Buy
543
+269
+98% +$20.4K ﹤0.01% 8130
2024
Q4 		$29.1K Buy
274
+237
+641% +$39.5K ﹤0.01% 7625
2024
Q3 		$6.9K Buy
+37
New +$8.04K ﹤0.01% 7948
2024
Q1 		– Hold
0
– -$7 – 9669
2023
Q4 		– Hold
0
– – – 9137
2023
Q3 		– Hold
0
– – – 8968
2022
Q4 		– Sell
-7
Closed -$9K – 10923
2022
Q3 		$9K Buy
7
+4
+133% +$7.16K ﹤0.01% 8580
2022
Q2 		$5K Buy
3
+2
+200% +$4.89K ﹤0.01% 8887
2022
Q1 		$3K Buy
+1
New +$3.91K ﹤0.01% 9451
2021
Q3 		– Sell
-1
Closed -$3K – 9797
2021
Q2 		$3K Buy
+1
New +$5.76K ﹤0.01% 8812

Other funds holding ISPC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
GCP
Gill Capital Partners Denver, Colorado $348M AUM 14.74% 1-Year Est. Return

UBS Group's ISPC Position: Q1 2026 in Review

UBS Group increased its iSpecimen (ISPC) stake by 735% in Q1 2026, buying an estimated $13.3K and bringing the position to 1,344 shares worth $8.44K. The position accounts for ﹤0.01% of the portfolio, ranked #8506.

UBS Group first reported a position in ISPC in Q2 2021 and has held it in 10 quarters since. The position peaked at $29.1K in Q4 2024. 9 funds tracked by Wall St. Rank hold ISPC as of Q1 2026.

  • UBS Group held 1,344 shares of iSpecimen worth $8.44K as of Q1 2026.
  • UBS Group bought 1,183 iSpecimen shares in Q1 2026, an estimated $13.3K.
  • iSpecimen made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8506 holding.
  • UBS Group first reported a position in iSpecimen in Q2 2021 and has held it in 10 quarters since.
  • UBS Group's iSpecimen position peaked at $29.1K in Q4 2024.
  • 9 funds tracked by Wall St. Rank held iSpecimen as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.